Produkty 903549-49-5

CAS 903549-49-5 występuje w naszej ofercie pod nazwami: 5-trans Latanoprost (free acid), 5–trans Latanoprost (free acid), Latanoprost Impurity 16, trans-Latanoprost Acid, trans-​Latanoprost acid. Oferty producentów: TargetMol, GLPBio, Hubei YoungXin, TRC, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 5 mg.

5-trans Latanoprost (free acid)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 3
od 1222,97
Zobacz produkt
5–trans Latanoprost (free acid)
GLPBio
  • opakowanie: 1mg, 10mg, 5mg
  • Warianty: 3
od 962,12
Zobacz produkt
Latanoprost Impurity 16
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
trans-Latanoprost Acid
TRC
  • opakowanie: 25mg, 5mg
  • Warianty: 2
Zobacz produkt
trans-​Latanoprost acid
MedChemExpress
  • opakowanie: 5 mg, 1 mg
  • Warianty: 2
od 844,46
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid (CAS 903549-49-5) to związek chemiczny o wzorze sumarycznym C23H34O5 i masie molowej 390.5 g/mol. Nazwa systematyczna IUPAC: (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid. InChIKey: HNPFPERDNWXAGS-MIDWJBHHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H34O5
Masa molowa390.5 g/mol
Nazwa IUPAC(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid
InChIKeyHNPFPERDNWXAGS-MIDWJBHHSA-N
SMILESC1[C@H]([C@@H]([C@H]([C@H]1O)C/C=C/CCCC(=O)O)CC[C@H](CCC2=CC=CC=C2)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: trans-Latanoprost Acid, trans-?Latanoprost acid, 5-trans Latanoprost (free acid), trans-atanoprost Acid, orb1693062
Powiązane formy tego związku
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid C23H34O5
(Z)-3,3,4,4-tetradeuterio-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid C23H34O5
Izomery (ten sam wzór sumaryczny)
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2-methylpropanoate C23H34O5
2-[[(1S,2S,3aR,9aR)-2-hydroxy-1-[(3R)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid C23H34O5
2-[[(1S,2S,3aR,9aR)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid C23H34O5
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid C23H34O5
[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C23H34O5
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H34O5
3-[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14,16-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H34O5
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3R)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid C23H34O5
(3E,4S)-3-[2-[(2aS,4aS,5R,8aS,8bR)-2a-hydroxy-8b-(hydroxymethyl)-2,2,4a-trimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-1H-cyclobuta[a]naphthalen-5-yl]ethylidene]-4-hydroxyoxolan-2-one C23H34O5
3-[(3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H34O5